Kolinpharma S.p.A.

BIT:KIP 주식 보고서

시가총액: €15.9m

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Kolinpharma 관리

관리 기준 확인 1/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Rita Petrelli

최고 경영자

n/a

총 보상

CEO 급여 비율n/a
CEO 임기no data
CEO 소유권n/a
경영진 평균 재임 기간데이터 없음
이사회 평균 재임 기간3.8yrs

최근 관리 업데이트

Recent updates

Kolinpharma (BIT:KIP) Is Looking To Continue Growing Its Returns On Capital

Jun 17
Kolinpharma (BIT:KIP) Is Looking To Continue Growing Its Returns On Capital

What Does Kolinpharma S.p.A.'s (BIT:KIP) Share Price Indicate?

Dec 01
What Does Kolinpharma S.p.A.'s (BIT:KIP) Share Price Indicate?

An Intrinsic Calculation For Kolinpharma S.p.A. (BIT:KIP) Suggests It's 46% Undervalued

Aug 25
An Intrinsic Calculation For Kolinpharma S.p.A. (BIT:KIP) Suggests It's 46% Undervalued

We Think Kolinpharma (BIT:KIP) Can Stay On Top Of Its Debt

Jun 08
We Think Kolinpharma (BIT:KIP) Can Stay On Top Of Its Debt

Do Kolinpharma's (BIT:KIP) Earnings Warrant Your Attention?

May 21
Do Kolinpharma's (BIT:KIP) Earnings Warrant Your Attention?

Is There An Opportunity With Kolinpharma S.p.A.'s (BIT:KIP) 35% Undervaluation?

May 03
Is There An Opportunity With Kolinpharma S.p.A.'s (BIT:KIP) 35% Undervaluation?

Some Shareholders Feeling Restless Over Kolinpharma S.p.A.'s (BIT:KIP) P/E Ratio

Apr 13
Some Shareholders Feeling Restless Over Kolinpharma S.p.A.'s (BIT:KIP) P/E Ratio

What Does Kolinpharma S.p.A.'s (BIT:KIP) Share Price Indicate?

Feb 20
What Does Kolinpharma S.p.A.'s (BIT:KIP) Share Price Indicate?

Is Weakness In Kolinpharma S.p.A. (BIT:KIP) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Dec 28
Is Weakness In Kolinpharma S.p.A. (BIT:KIP) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

These 4 Measures Indicate That Kolinpharma (BIT:KIP) Is Using Debt Reasonably Well

Nov 22
These 4 Measures Indicate That Kolinpharma (BIT:KIP) Is Using Debt Reasonably Well

CEO

Rita Petrelli

no data

테뉴어

Dr. Rita Paola Petrelli is the Co-Founder, Chairwoman of The Board, Chief Executive Officer and Chief Financial Officer of Kolinpharma S.p.A. Dr. Petrelli is chartered accountant, auditor and technical-leg...


이사회 구성원

이름위치테뉴어보상소유권
Rita Petrelli
Co-Founderno data데이터 없음데이터 없음
Massimo Mantella
CEO & Director4.4yrs데이터 없음데이터 없음
Francesco Spano
Independent Directorno data데이터 없음데이터 없음
Pierluigi Pipolo
Chairman of the Board of Statutory Auditors3.8yrs데이터 없음데이터 없음
Giannunzio Corazza
Non-Executive Directorno data데이터 없음데이터 없음
Edoardo Ferragina
Non-Executive Directorno data데이터 없음데이터 없음
Maurizio Altini
Independent Directorno data데이터 없음데이터 없음
Giulio Centemero
Standing Auditor3.8yrs데이터 없음데이터 없음
Roberto Giannella
Standing Auditor3.8yrs데이터 없음데이터 없음

3.8yrs

평균 재임 기간

경험이 풍부한 이사회: KIP 의 이사회경험(평균 재직 기간 3.8 년)으로 간주됩니다.